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Mitochondrial DNA Deletions Serve as Biomarkers
of Aging in the Skin, but Are Typically Absent
in Nonmelanoma Skin Cancers
Alex Eshaghian1,2,3, Ruth A. Vleugels1,2, Jeffrey A. Canter4, Michel A. McDonald2, Thomas Stasko2 and
James E. Sligh1,2,3
The potential role of mitochondrial DNA (mtDNA) deletions in nonmelanoma skin cancer (NMSC) and in
cutaneous photoaging was explored using a genetic approach. Tumors and photodamaged tumor-free ‘‘margin’’
skin were obtained from NMSC patients undergoing excision and the mtDNA from these specimens was
screened for the presence of deletions using long extension PCR. mtDNA deletions were abundant in margin
tissue specimens from older patients and their number correlated with the patient age. There was a statistically
significant difference between the number of mtDNA deletions in tumors and margins. Fewer deletions were
detected in the tumors than the margins and the tumors often had no deletions, implying a potential selection
for full-length mtDNA or perhaps a protective role for mtDNA deletions in the process of tumorigenesis. The
observed mtDNA deletions from skin were often unreported (19 of 21 deletions), but typically shared structural
features with mtDNA deletions reported in other tissues. Some mtDNA deletions were detected from the skin
of multiple individuals, including 3,715 and 6,278-base pair (bp) deletions, whose frequencies approached that
of the previously well-characterized 4977-bp ‘‘common’’ deletion. These data support the use of mtDNA
mutations as biomarkers of photoaging in the skin.
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INTRODUCTION
Mitochondria have well-recognized roles both in the
generation of cellular energy and as mediators of cellular
events such as apoptosis. There is emerging evidence for
mitochondrial DNA (mtDNA) changes in the complex
processes of cellular aging and neoplasia (Wallace, 1999;
Copeland et al., 2002; Eng et al., 2003). The human mtDNA
is a maternally inherited, circular, double-stranded DNA of
16,569 base pairs (bp), encoding 22 tRNAs, two rRNAs, and
13 polypeptides, all of which are subunits of respiratory
enzyme complexes in the electron transport chain (Giles
et al., 1980; Anderson et al., 1981, 1999). The remainder of
the proteins that function in the mitochondrion are encoded in
the nucleus and imported into the mitochondrion. As the
mitochondria contain multiple copies of the mtDNA and cells
may contain thousands of mitochondria, newly acquired somatic
mutations are heteroplasmic in nature. However, replicative
segregation may allow mutant mtDNA molecules in some cells
to become prominent, or even to become the exclusive mtDNA
in the cell, a condition known as homoplasmy.
The mitochondrion serves as the major site for production
of adenosine triphosphate through the process of oxidative
phosphorylation. Reactive oxygen species (ROS), natural
byproducts of this pathway, can damage lipids, proteins, and
DNA (Shigenaga et al., 1994; Richter, 1995). mtDNA has a
high mutation rate due to its lack of histones, decreased
capacity for repair, and close proximity to the site of ROS
formation (Wallace et al., 1992). Imbalances between
oxidative stress and free radical scavenging enzymes have
been suggested as the underlying causes of most of the
mtDNA damage (Shoffner et al., 1989; Lu et al., 1999; Shin
et al., 2005). Recent studies have implicated singlet oxygen
as a key intermediate in the UVA-induced generation of the
4,977 bp ‘‘common’’ mtDNA deletion in vitro (Berneburg
et al., 1999) and that supplementation with the adenosine
triphosphate-producing precursor creatine can prevent the
4,977 bp ‘‘common’’ deletion from becoming prominent and
exerting its effects on adenosine triphosphate synthesis and
oxygen consumption (Berneburg et al., 2005). A role for
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mutations in mitochondrial proteins has been suggested by
many recent studies that found a high frequency of mtDNA
mutations in a variety of cancers, including colon, bladder,
and lung (Polyak et al., 1998; Fliss et al., 2000).
In contrast to other tissues, the skin is subject to both
chronological aging as well as environmental insult in the
form of UVR. mtDNA mutations have been found primarily in
sun-exposed skin over sun-protected skin (Pang et al., 1994;
Yang et al., 1994, 1995; Berneburg et al., 1997, 1999, 2004;
Birch-Machin et al., 1998; Ray et al., 2000; Koch et al., 2001;
Harbottle et al., 2004; Krishnan et al., 2004). The most
common mutation found in aging tissues is the 4,977-bp
‘‘common’’ deletion (Cortopassi and Arnheim, 1990; Ikebe
et al., 1990; Cortopassi et al., 1992; Wallace, 1992; Sciacco
et al., 1994; Brierley et al., 1998; Nagley and Wei, 1998).
Although this mutation has been found in numerous tissues
that are not susceptible to UVR, its presence in the skin has
primarily been associated with sun exposure. In fact, the
common deletion has been shown to be inducible both in
vitro and in vivo in human skin and is thought to occur as a
result of mtDNA damage mediated through singlet oxygen
(Berneburg et al., 1999, 2004). Additionally, the 4,977-bp
‘‘common’’ deletion has been proposed to be a biomarker of
photo-aged skin because the level of heteroplasmy in the sun-
exposed skin increases with age, while such levels are not
increased in sun-protected skin (Yang et al., 1994, 1995;
Birch-Machin et al., 1998).
mtDNA point mutations have now been identified in
many types of tumors (Polyak et al., 1998; Copeland et al.,
2002). A number of hypotheses have been proposed to
explain this phenomenon. A possible explanation for mutant
mtDNA in tumor cells is that mutant mtDNAs might alter
mitochondrially mediated apoptotic pathways to escape cell
death (Penta et al., 2001). Alternatively, the mtDNA changes
may endow the tumor cell with a selective growth advantage
directly or combine with acquired nuclear encoded muta-
tions to provide an advantage (Flury et al., 1976; Torroni
et al., 1990; Penta et al., 2001). Perhaps the mutant mtDNAs
produce protein changes resulting in the liberation of slightly
increased levels of ROS. Low levels of increased ROS have
been proposed to be mitogenic in contrast to high levels of
ROS that are toxic (Toyokuni et al., 1995; Wei, 1998; Davies,
1999; Penta et al., 2001). While various mutations have been
associated with photo-aging and neoplasia, it is unclear
whether a characteristic signature of mtDNA mutations exists
in these conditions.
We sought to characterize mtDNA changes in the
photoaged skin and tumors from patients with nonmelanoma
skin cancer (NMSC). Our objective was to determine if
NMSC has a distinct mtDNA deletion signature. Numerous
mtDNA deletions were detected from photoaged, tumor-free
skin of multiple individuals including novel 3,715- and
6,278-bp deletions and the 4,977-bp ‘‘common’’ deletion,
and the number of mtDNA deletions observed in the surgical
margins correlated with the patient age. In contrast, tumors
contained fewer mtDNA deletions than the margins, suggest-
ing a potential selection for full-length mtDNA in NMSC
formation, or perhaps a protective role of mtDNA deletions in
the formation of NMSC. Together, these data suggest that
mtDNA mutations may potentially be used as biomarkers of
photoaging in the skin, but not as characteristic mutation
signatures of NMSC itself.
RESULTS
Long-extension PCR reveals different mtDNA deletion patterns
in tumors versus margins
To determine whether specific deletions provide a signature
for tumors, we isolated DNA from both NMSC tumors and
tumor-free photo-aged ‘‘margin’’ skin from patients. In all,
98% of the mitochondrial genome was amplified using
primers oriented in opposite directions in the cytochrome b
gene using long-extension PCR (Materials and Methods).
These PCR products were resolved by field inversion gel
electrophoresis to determine whether deleted mtDNA species
are present (Figure 1a). mtDNA was amplified from tumors (T)
and margins (M) from patients with basal cell carcinoma
(BCC) and squamous cell carcinoma of various ages or from a
30-year-old control patient (C) with no history of skin cancer.
Full-length mtDNA is indicated by the amplification of a
16.3-kb product, and is the only species observed in the
control patient. mtDNAs harboring deletions are indicated by
the presence of shorter fragments. While it appears that
tumors contain predominantly or exclusively full-length
mtDNA, margin samples, on the other hand, contain readily
detectable mtDNA deletions (Figure 1a). Older patients had
more mtDNA deletions, and sometimes deleted mtDNAs
were the only species detected in this assay. The number of
deleted mtDNA species strongly correlated with patient age
in margins (Figure 1b; Spearman rank correlation coefficient
r¼0.93, P¼ 0.003) but not in tumors (Figure 1b; r¼0.37,
P¼0.33). Furthermore, a comparison of the number of
deleted mtDNA species present in tumor versus margin
samples was statistically significant (P¼ 0.009) using a
nonparamentric Wilcoxon signed-rank test.
Characteristics of mtDNA deletions in photoaged skin
To determine the breakpoints of the deletions identified in
Figure 1a, various primer pairs were used to amplify all
regions of the mtDNA. In this experiment, the primers were
designed to be distant, while the extension times were short.
(Parameters and primer sequences are given in Materials and
Methods and Table S1, respectively.) In this way, only
mtDNAs containing deletions will be amplified. Such PCR
products were resolved by gel electrophoresis, extracted, and
sequenced. Table 1 summarizes the deletions identified.
While the 4,977-bp ‘‘common’’ deletion was detected
frequently, a number of novel deletions were also identified,
whose sizes range from 591 to 8,257 bp. Most deletions had
3–15 bp direct or indirect repeats. The majority of the
deletions were in the major arc of the mtDNA, the region
between the origins of replication of the two strands. Finally,
all mutations caused deletions of multiple genes. The
deletions identified using this method are presented in Table 1
and Figure S1.
Figure 2 shows the sequences of the breakpoints of two
previously undescribed deletions each observed in the
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margins of multiple patients. The 6,278-bp deletion (panel A)
occurs at an 11-bp direct repeat present in both the MTCO1
and MTND5 genes and the 3,715-bp deletion (panel B)
occurs at a 10-bp direct repeat present in both the MTRNR1
and MTND2 genes. Additionally, the frequency of detection
of these novel deletions approached that of the 4,977-bp
‘‘common’’ deletion.
A novel mtDNA species containing three deletions was
identified in an 82-year-old patient (Figure 3). In this
mutation, 10 or 21 bp are retained, while 1,647, 591, and
3,572 bp are deleted. Only one of the three deletions
contains a direct repeat of only 3 bp.
Two deletions that contain the same 50 breakpoint were
observed in the margin samples: 3,715 bp (1,491:5,206 D10/10)
and 3,833 bp (1,491:5,322 D9/9) (Table 1). The 9-bp direct
repeat occurs four times in the human mtDNA at positions
1,491, 5,206, 5,323, and 10,087. However, other deletion
products such as 1,491:10,087, 5,206:5,323, 5,206:10,087,
or 5,323:10,087 were not observed.
Quantification of deletions
To determine the heteroplasmy levels of the common
deletion in margin samples, we used real-time PCR. Some
of the margin samples were chemically treated to allow for
the separation of dermis from epidermis using microscopic
dissection. DNA from these samples was isolated and
amplified using primers flanking the breakpoints in the case
of wild-type and mutant species (Materials and Methods).
Figure 4 shows the quantitative analysis for the ‘‘common’’
4,977-bp deletion. The heteroplasmy level is plotted against
patient age. Levels of heteroplasmy from the dermis are
shown in red, from epidermis, green, and from unsplit
samples, black. Split samples from the same patient are
indicated by squares and triangles. For the 4,977-bp
‘‘common’’ deletion, there is a positive correlation between
patient age and heteroplasmy level when all data points are
considered (Spearman rank correlation coefficient r¼0.31,
P¼0.045). We also observed that there was a consistently
higher level of heteroplasmy of the 4,977 bp ‘‘common’’
deletion in dermis as compared to epidermis from the same
excised sample when split specimens were analyzed.
DISCUSSION
While numerous deletions were observed in margin samples,
fewer were observed in the tumors (Figure 1). Screening for
mtDNA deletions detected the 4,977-bp ‘‘common’’ deletion
(Table 1), which is reported to be one of the biomarkers of
photoaged skin (Birch-Machin et al., 1998). In agreement
with this theory, there was a positive correlation between the
level of heteroplasmy of this deletion and the patient’s age
(Figure 4). Deviations from this linear relationship may be
secondary to variations in levels of accrued sun exposure; as
such information was not available for this study. We found a
consistently higher level of heteroplasmy of the 4,977-bp
‘‘common’’ deletion in the dermis as compared to the
epidermis in our split samples, consistent with previous
studies (Birch-Machin et al., 1998). In addition to the 4,977-
bp ‘‘common’’ deletion, we have found a number of
previously unreported deletions (Table 1), including novel
3,715- and 6,278-bp deletions present in numerous photo-
aged skin samples. While these deletions have not been
previously reported, they are structurally similar to the 4,977-
bp ‘‘common’’ deletion in that they generally contain short
direct or indirect repeats at the breakpoints, and a single copy
of the repeat is left behind in the deleted molecule. The
structural similarities between the mtDNA deletions observed
in the skin and those seen in tissues not exposed to UVR
(Kogelnik et al., 1996) imply a potential common factor in
their generation or resolution. Furthermore, the number of
novel deletions in photoaged skin not reported in other
tissues suggests that skin may be more vulnerable to such
mutations via direct exposure to UVR.
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Figure 1. (a) Resolution of deleted mtDNA species. mtDNA isolated from
the representative tumor (T) and margin (M) was amplified and resolved. An
inverted image of a 0.8% agarose gel is shown. The age of the patient from
whom the tumor and margin samples were isolated is indicated above the
T and M. The first seven patients had BCC and the last two had squamous cell
carcinoma. DNA from a 30-year-old control patient (C) is shown at the right.
A molecular weight marker is shown on the left; sizes of marker fragments are
given in kb. Full-length mtDNA is indicated by the amplification of a 16.3-kb
product (the only species observed in the control patient). mtDNAs harboring
deletions are indicated by the presence of shorter fragments. (b) The number
of deleted mtDNA species is plotted versus age for the tumor and margin
samples in (a). The Wilcoxon signed-rank test was used to compare non-
normally distributed variables in paired samples.
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There was a striking difference between the mtDNA
deletion patterns observed in tumors as compared to margins.
Using long-extension PCR, mtDNA deletions were readily
detected in the margin skin of the patients undergoing NMSC
surgery. However, we observed far fewer mtDNA deletions in
the tumors compared to margins, which was a statistically
significant finding. In fact, the tumors often had no detectable
mtDNA deletions despite the fact that long-extension PCR
Table 1. MtDNA deletions detected
Age Type Breakpoints Size (bp) Fl. Rep. Genes deleted Ref.
44 Novel 1,491:5,2061 3,715 D 10/10 MTRNR1-MTND2 0
51 Reported 534:4,430 3,895 D 13/13 MTTFH-MTTM 3
Novel 7,682:13,722 6,039 NR MTCO2-MTND5 0
54 Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
Novel 7,468:1,5989 8,521 D 9/9 MTTS1-MTTP 0
54 Novel 1,491:5,2061 3,715 D 10/10 MTRNR1-MTND2 0
Novel 1,491:5,323 3,831 D 9/9 MTRNR1-MTND2 0
62 Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
Novel 7,817:16,075 8,257 D 2/2 MTCO2-MTDL 0
Novel 7,663:13,804 6,140 D 5/5 MTCO2-MTND5 0
62 Novel 7,398:13,6772 6,278 D 11/11 MTCO1-MTND5 0
65 Novel 1,491:5,2061 3,715 D 10/10 MTRNR1-MTND2 0
67 Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
69 Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
Novel 7,957:13,370 5,412 D 4/4 MTCO2-MTND5 0
71 Novel 7,398:13,6772 6,278 D 11/11 MTCO1-MTND5 0
Novel 8,131:13,570 5,438 I 12/14 MTCO2-MTND5 0
Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
73 Novel 1,491:5,2061 3,715 D 10/10 MTRNR1-MTND2 0
Novel 7,398:13,6772 6,278 D 11/11 MTCO1-MTND5 0
Novel 7,853:13,887 6,033 NR MTCO2-MTND5 0
76 Novel 7,398:13,6772 6,278 D 11/11 MTCO1-MTND5 0
Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
78 Novel 8,299:13,153 4,853 I 8/9 MTTK-MTND5 0
80 Novel 7,398:13,6772 6,278 D 11/11 MTCO1-MTND5 0
81 Novel 8,137:14,771 6,633 D 3/3 MTCO2-MTNC9 0
82 Novel 7,912:9,5603 1,647 NR MTCO2-MTCO3 0
Novel 8,568:12,976 4,407 D 8/8 MTATP6-MTND5 0
Novel 9,570:10,1623 591 NR MTCO3-MTND3 0
Novel 10,183:13,7563 3,572 D 3/3 MTND3-MTND5 0
82 Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
Novel 8,525:13,716 5,189 NR MTATP8-MTND5 0
85 Common 8,469:13,447 4,977 D 13/13 MTATP8-MTND5 96
Novel 7,728:13,806 6,077 I 13/15 MTCO2-MTND5 0
Novel 8,030:14,334 6,303 D 3/3 MTCO2-MTND6 0
85 Novel 8,464:13,138 4,673 NR MTATP8-MTND5 0
88 Novel 8,441:14,505 6,063 I 13/15 MTATP8-MTND6 0
Deletions were identified in 20 of 29 patient samples. The patient’s age, deletion type, deletion breakpoints, deletion size, flanking repeats (Fl. Rep.), genes
deleted, and number of references in the Mitomap database (Ref.) are shown. D: direct repeat. I: indirect repeat. NR: no repeat.
1Novel 3,715-bp deletion found in high frequency.
2Novel 6,278-bp deletion found in high frequency.
3Complex triple deletion.
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may be biased toward preferential amplification of smaller
(deleted) products (Kajander et al., 1999). Deletions that were
observed in tumors were also found in the corresponding
margins. This observation is likely due to the nature of the
Mohs surgical excision procedure, which generated margin
specimens that were histologically confirmed to be tumor-
free, while the tumor samples themselves potentially con-
tained an admixture of malignant and nonmalignant cells.
Taken together, these data support the idea that there is no
specific mtDNA deletion signature in NMSC tumors (Yang
et al., 2004). The presence of full-length mtDNA in these
tumors, despite the fact that they are arising in areas of skin
characterized by abundant mtDNA deletions, may be
indicative of a selective process for full-length mtDNA in
the process of NMSC tumorigenesis. Alternatively, the
absence of mtDNA deletions in tumors may indicate a
potential protective role for mtDNA deletions in keratino-
cytes. Perhaps the accumulation of mtDNA deletions during
skin aging creates a bioenergetic profile that prohibits the
damaged keratinocytes from undergoing a malignant trans-
formation. It is also possible that high levels of mtDNA
deletions in a proliferating malignant keratinocyte may trigger
apoptosis. These findings also argue against theories propos-
ing that stochastic segregation of mutant mtDNAs can lead to
mutant mtDNA homoplasmy in tumors (Coller et al., 2001).
The mechanism of formation of such mtDNA deletions has
been proposed to be a slip mispairing of the repeats during
replication (Schon et al., 1989; Shoffner et al., 1989; Mita
et al., 1990; Berneburg et al., 1999; Samuels et al., 2004). In
order for such a mutation to occur, however, both break-
points must be single stranded simultaneously, which does
not normally occur. However, the sequences flanking the
repeats or the sequences within the repeats may render the
DNA susceptible to structural conformations allowing mis-
pairing (Hou and Wei, 1996). Our findings show that most
deletions identified contain such repeats (Table 1), supporting
the slip replication model. The novel 3,715- and 6,278-bp
deletions contain 10- and 11-bp direct repeats, respectively,
similar in size to that of the 4,977-bp ‘‘common’’ deletion
(13 bp). Additionally, the novel 6,278-bp deletion contains a
homopolymeric track of seven consecutive cytosine residues
interrupted by a single adenosine residue within its repeated
breakpoint sequence. Such sequences have been proposed to
take on structural characteristics allowing for mispairing
to occur (Fullerton et al., 2001). These features may explain
the reason why the frequencies of detection of the novel
3,715- and 6,278-bp deletions approached that of the
4,977-bp ‘‘common’’ deletion. It has been proposed that
ROS, which are normally generated in response to UVR
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Figure 2. The sequences of the (a) 6,278-bp and (b) 3,715-bp deletion
breakpoints from representative samples are shown. In the 6,278-bp
deletion, there is a direct repeat of 11 bp (CCCCACCCTAC, underlined) in the
MTCO1 and MTND5 genes; the breakpoints are 7398:13,677. In the 3,715-
bp deletion, there is a direct repeat of 10 bp (CACCCTCCTC, underlined) in
the MTND2 and MTRNR1 genes; the breakpoints are 1,489:5,206.
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Figure 3. Complex triple deletion. A novel complex triple deletion was
detected from the skin of an 82-year-old patient. The deletion breakpoints
were sequenced and are shown under the solid lines. The deletions (dotted
lines) are identified by ‘‘D’’ and their size. D: direct repeat at the deletion
breakpoint. NR: no repeats at the deletion breakpoint.
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Figure 4. 4,977-bp deletion heteroplasmy levels. The percent heteroplasmy
as quantified by real-time PCR is plotted against patient age. Black circles
indicate unsplit samples. For split samples, red indicates dermis and green
epidermis. Dermis and epidermis from the same patient are indicated by
squares or triangles. A best-fit line is added (linear trendline in Microsoft
Excel), the correlation coefficient is 0.21.
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(Scharffetter-Kochanek et al., 1997), play a role in the
generation of the 4,977-bp ‘‘common’’ deletion (Berneburg
et al., 1999). Thus, it is not surprising that so many unreported
mtDNA deletions were identified in photoaged skin given its
role as a barrier to UVR. In addition, nucleotide excision
repair may be deficient in mitochondria (Clayton et al.,
1974). This deficiency may result in increased mtDNA
damage in the form of DNA photoadducts in tissues exposed
to UVR. These photoadducts may trigger the formation of
mtDNA deletions, although the specific mechanism for this
possibility is unclear. It is likely that persistent mtDNA
photoadducts would block mtDNA replication and may be
a mechanism by which mutated mtDNAs are ultimately
diluted from replicating mtDNAs in cell division (Clayton
et al., 1974).
An unreported complex triple deletion was identified on a
single strand of mtDNA (Figure 3 and Table 1). This specimen
was examined for intermediate deleted products, but none
were found (data not shown). Furthermore, the breakpoints of
this deletion were atypical in that two of the three deletions
had no repeats and one had a 3-bp direct repeat, suggesting a
different mechanism of formation. Perhaps this type of
deletion is indicative of a more serious mtDNA insult than
typical UV exposure, such as from a different environmental
or systemic insult.
While the 4,977-bp ‘‘common’’ deletion has been
proposed to be a biomarker for photoaging, it may reflect
only a small portion of total mtDNA damage. For example,
the frequencies of detection of the 3,715- and 6,278-bp
deletions approach that of the 4,977-bp ‘‘common’’ deletion,
implicating that these deletions may prove valuable as
additional markers of photoaging in the skin. Additionally,
tumor-free photoaged skin contains an abundance of various
deletions (Table 1), not merely the novel 3,715- and 6,278-bp
deletions nor even the 4,977-bp ‘‘common’’ deletion. Thus,
the use of the 4,977-bp ‘‘common’’ deletion as a biomarker
for photoaged skin may indeed be the tip of the iceberg.
These data are consistent with previous studies suggesting
the potential use of mtDNA deletions as biomarkers of
cutaneous photoaging (Birch-Machin et al., 1998; Ray et al.,
2000; Koch et al., 2001; Krishnan et al., 2004; Yang et al.,
2004) in that deletions are common in photoaged skin.
Deleted mtDNA products observed in tumors (such as those
in the 80-year-old BCC patient (Figure 1a)) were also
observed in the margin, suggesting that the tumor contained
an admixture of tumor and tumor-free cells. This is consistent
with previous studies showing that when tumor cells are
microdissected and separated from tumor-free cells, deletions
were not observed within experimental limits (Birch-Machin
et al., 1998). It is also consistent with a previous study
showing the absence of mtDNA deletions in colorectal
carcinomas (Penta et al., 2001). A previous study that
specifically examined mtDNA deletions in NMSC patients
reported a different pattern of mtDNA deletions in the tumors
compared to that in the perilesional skin (Durham et al.,
2003). In their study, Durham et al. (2003) examined the
patterns of mtDNA deletions using an approach that divides
the mtDNA into two amplifiable fragments. The total number
of deleted species amplified from the perilesional tissue
generally exceeded the number of deleted species identified
in tumor tissue, which is consistent with our observations.
Additionally, the ratio of deletions in the major arc to that of
the minor arc is highly consistent between their study (20:4)
and ours (20:3; Figure S1). However, Durham et al. (2003)
often observed mtDNA deletions which appeared to be
specific to the tumors, as they were not visualized in the
perilesional skin. This observation is in contrast with our
study that showed that mtDNA deletion patterns present in
the tumor specimens were also present in the adjacent
margin samples, and failed to identify mtDNA deletion
species that were unique to the tumor itself. Perhaps the
differences in our results and these results can be explained
by the method of acquisition of surgical specimens. In the
case of this study, the use of the Mohs surgical technique
provides tumor tissue with minimal admixed nontumor
tissue, which may explain the presence of the bands
corresponding to deleted mtDNA species in the 80- and
63-year-old BCC patients (Figure 1a). It is also possible that
differences in experimental design such as PCR amplification
parameters may be responsible for the observed differences
between these two studies.
ROS induce mtDNA deletions by causing strand breaks in
the mtDNA (Shoffner et al., 1989; Berneburg et al., 1999).
Such breaks can allow for deletions via a slip repair
mechanism whereby repeated sequences are misannealed
during replication and UVR-induced breaks in the DNA
cause the intervening portion of the mtDNA to be deleted in
the replicated copy (Schon et al., 1989; Shoffner et al., 1989;
Mita et al., 1990; Madsen et al., 1993; Berneburg et al.,
1999). Such deletions would lead to a loss of multiple genes
required for oxidative phosphorylation, usually including
multiple tRNAs which are required for protein synthesis of all
polypeptides encoded by the mtDNA. This deficiency of all
mitochondrially encoded proteins may induce a state of
respiratory deficiency at a level that does not support an
adequate biochemical environment for the development of
neoplasia. This may explain why mtDNA point mutations
that only induce a partial respiratory deficiency in humans
(Petros et al., 2005) or mice (Sligh et al., 2000) are seen in
association with hyperproliferative cellular phenotypes such
as prostate cancer or optic nerve head hamartomas. Increased
cellular ROS generated as a result of dysfunctional mitochon-
drial electron transport may be implicated in this neoplastic
process. On the contrary, studies of mtDNA deletions present
in cells or in the germ line of transgenic mice have not been
associated with maintenance of a neoplastic phenotype
(Inoue et al., 2000; Akimoto et al., 2005). As mtDNA
deletions accrue in photo-aged skin, they may be useful as
biomarkers of the combined effects of chronological aging
and UV exposure. Additionally, specific mtDNA deletions
may complement other deletions and the potential level of a
single mtDNA deletion may plateau with time as it adversely
affects the bioenergetic properties of the cell. Measurement of
a panel of deletions may be a more useful assay of
photodamage than heteroplasmy levels of any single deletion
alone. An analysis of the number of different deletions
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detectable by long-extension PCR, for example, may be a
potential indicator of photodamage. Quantitative analysis of
other deletions such as those in Table 1, particularly the
3,715- and 6,278-bp deletions (whose frequencies approach
that of the 4,977-bp ‘‘common’’ deletion), in addition to the
4,977-bp ‘‘common’’ deletion may be useful for this purpose.
Future studies will include correlational analyses of these two
frequently occurring deletions with age.
MATERIALS AND METHODS
Tissue acquisition
In all, 29 skin cancer tumor specimens and tumor-free margin skin
specimens were obtained from the Mohs micrographic surgery unit
at the Vanderbilt Clinic using a protocol approved by the Vanderbilt
University Institutional Review Board (25 BCC and four squamous
cell carcinoma). Some excised skin specimens were soaked in 0.5 M
NaBr at 41C overnight to enable the epidermis to be physically
peeled from the dermis using microscopic dissection (total of five
specimens, all from patients with BCC). All work adhered to the
Declaration of Helsinki Principles.
DNA isolation
Approximately 25 mg of tissue was incubated for a minimum of 8 hours
at 551C rocking in 400ml lysis solution (100 mM Tris, pH 8.0, 50 mM
EDTA, 150 mM NaCl, 0.5% SDS) supplemented with 15ml of 15 mg/ml
proteinase K solution (Roche; Indianapolis, IN). Proteins were removed
using ammonium acetate. DNA was precipitated using isopropanol,
washed with 70% ethanol, and resuspended in sterile 10 mM Tris, 1 mM
EDTA, pH 8.0. DNAs were stored at 201C until further use.
Long-extension PCR
PCR reactions were set up with a total volume of 50 ml per reaction
using the Expand Long Template PCR System (Roche; Indianapolis,
IN). Each reaction included final concentrations of 1 buffer, 2 mM
each deoxynucleoside triphosphate, and 400 nM of each primer. In
all, 0.5 ml template DNA and 0.7 ml enzyme were used per reaction.
Primers H15473F and H14841R were used (sequences in Table S1).
Long-extension PCR was performed with an initial denaturation for
2 minutes at 921C; followed by 10 cycles of denaturation for
10 seconds at 921C, annealing for 30 seconds at 621C, and
elongation for 18 minutes at 681C, followed by 20 cycles of
denaturation for 10 seconds at 921C, annealing for 30 seconds at
621C, and elongation for 18 minutes 10 seconds þ 10 seconds per
cycle at 681C. PCR products were stored at 41C until further use.
Field inversion gel electrophoresis
Long-extension PCR products were resolved on a 20-cm-long 0.75%
agarose gel at 125 V with the buffer recirculating for 20–24 hours.
The electric field was inverted using a PPI-200 Programmable Power
Inverter (MJ Research; Watertown, MA) programmed to optimally
resolve fragments from 0.5 to 40 kb using Gel Times software for
Macintosh (MJ Research; Watertown, MA). The gel was initially run
for approximately 15 minutes without field inversion. Products were
visualized with ethidium bromide staining.
Deletion breakpoint analysis
To determine the breakpoints of the deletions identified in the long-
extension PCR experiment, traditional PCR was used with distantly
spaced primers and short extension times. In this way, only samples
containing deletions would produce a product. PCR reactions were
set up with a total volume of 25ml per reaction. Each reaction
included final concentrations of 1 buffer, 1.5 mM MgCl2, 200 nM
each deoxynucleoside triphosphates, and 200 nM of each primer.
Also, 0.5ml template DNA and 2.5 U Taq polymerase (Promega;
Madison, WI) were used per reaction. Primer sequences are listed in
Table S1. PCR parameters were set up with an initial denaturation for
2–5 minutes at 941C, followed by 30–35 cycles of denaturation for
30 seconds at 941C, annealing for 30 seconds, and elongation at
721C. Annealing temperatures and elongation times for the various
primer pairs are listed in Table S1. A final elongation was for
5 minutes at 721C. PCR products were stored at 41C until further
use. PCR products were resolved on agarose gels to determine
their size.
DNA sequencing
PCR products were resolved on agarose gels and deleted fragments
were gel purified using Gel Extraction kits (Qiagen; Santa Clarita,
CA) or incubation with exonuclease I (New England Biolabs;
Beverly, MA) and shrimp alkaline phosphatase (Roche; Indianapolis,
IN) at 371C for 30 minutes, followed by heat inactivation at 851C for
15 minutes. The DNAs were sequenced using one or both of the
primers used to amplify them using the ABI Prism 3700.
Real-time PCR
Real-time PCR was used to detect the heteroplasmy level for the
4,977-bp deletion. Real-time PCR reactions were set up using the iQ
SYBR Green system (Bio-Rad; Hercules, CA) with a total volume of
20 ml per reaction. Each reaction included final concentrations of
1 iQ SYBR Green Supermix (Bio-Rad; Hercules, CA) and 500 nM
of each primer. Equal amounts of template DNA was used for wild
type and deletion. Primers used were H8388F, H8493R, and
H13477R. The sequences are: H8388F, 50-ATGGCCCACCATAAT
TACCC-30; H8493R, 50-TTTTATGGGCTTTGGTGAGG-30; and
H13477R, 50-GCTAATGCTAGGCTGCCAAT-30. These primers were
designed to span one breakpoint of the 4,977-bp deletion. To
determine the quantity of wild-type mtDNA, the primers H8388F
and H8493R were used. To determine the quantity of mtDNA
containing the 4,977-bp deletion, the primers H8388F and H13477R
were used. Since the elongation time is short (30 seconds), PCR
products corresponding to wild-type mtDNA were not amplified
when H8388F and H13477R were used (data not shown). The
heteroplasmy level was calculated as the quantity of deleted mtDNA
divided by the sum of the wild-type mtDNA and the deleted mtDNA.
Real-time PCR was performed on an iCycler (Bio-Rad; Hercules, CA)
with an initial denaturation for 5 minutes at 951C, followed by 35
cycles of denaturation for 30 seconds at 951C, annealing 30 seconds
at 551C, and elongation for 30 seconds at 721C, followed by a melt
curve analysis from 951C to 41C in 0.51C increments for 10 seconds
per step. PCR products were resolved on agarose gels to ensure that
the products were of appropriate size.
Statistical methods
Continuous variables that were normally distributed are described by
the mean and SD, while those not normally distributed are
summarized by the median and interquartile range. The Shapiro–-
Wilk test was used to determine if continuous variables were
342 Journal of Investigative Dermatology (2006), Volume 126
A Eshaghian et al.
Mitochondrial DNA Deletions as Biomarkers of Photoaged Skin
normally distributed. The Wilcoxon signed-rank test was used to
compare non-normally distributed continuous variables in paired
samples (number of tumor deletions versus number of margin
deletions in the same individual). Spearman rank correlation was
used to measure the strength of association between two non-
normally distributed continuous variables. The level of significance
was set at 0.05. All statistical analyses were performed using STATA
8.0 (College Station, TX).
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SUPPLEMENTARY MATERIAL
Figure S1. Characterized deletions. The deletions characterized in Table 1 are
presented as horizontal bars. Genes are shown above. *Complex triple
deletion (Figure 3).
Table S1. Primers, annealing temperatures, and elongation times used to
amplify mtDNAs identified to contain deletions. Primers are listed in pairs in
which they were used. AT: Annealing temperature, given in 1C. ET: elongation
time, given in seconds.
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